CVRX Stock Price, Chart, Stats & News
CVRx, Inc. (CVRX) does not currently pay a dividend.
CVRX chart
Fundamentals
Gross margin | 85.33% |
Operating margin | -90.49% |
Pretax margin | -94.13% |
Net margin | -94.10% |
Effective tax rate | 0.01% |
ROA | -50.87% |
ROE | -99.33% |
D/E | 1.29x |
Interest coverage ratio | -8.80x |
CVRX valuation
P/E | – |
P/S | 4.14x |
P/B | 5.94x |
P/CF | -5.82x |
P/FCF | -5.75x |
P/OCF | -5.82x |
PEG | 2.95x |
EV multiple | -5.45x |
About
CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with heart failure characterized by reduced ejection fraction, often referred to as systolic heart failure. The company employs a diverse distribution strategy, leveraging its internal sales force, alongside sales agents and independent distributors, to reach markets across the United States, Germany, the wider European continent, and other global territories.
Similar securities
Based on sector and market capitalization
